Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ACTL6B	"ACTL6, BAF53B"	ENSG00000077080	"Actin like 6B"	O94805	7	100643097-100656448	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 20.7;pituitary gland: 15.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.0;Excitatory neurons: 22.1;Horizontal cells: 6.7;Inhibitory neurons: 19.0"	"Group enriched"	"Detected in some"	11	"glioma: 3.9;pancreatic cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	76	"SCLC-21H: 28.5;SH-SY5Y: 28.7"	"Low region specificity"	"Detected in all"							HPA045126	Uncertain		Approved	"Nucleoli rim,Mitotic chromosome"		Yes	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoli rim, Mitotic chromosome"		"HPA045126: AB_10961265"	"unprognostic (3.31e-2)"	"unprognostic (6.89e-2)"		"unprognostic (4.59e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.27e-3)"	"unprognostic (4.81e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.01e-4)"	"unprognostic (1.64e-1)"	"unprognostic (6.84e-2)"		"unprognostic (2.01e-2)"	0.0	1.8	13.8	0.0	14.5	0.0	0.0	9.4	20.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.9	8.5	0.0	0.0	0.0	0.0	4.4	1.8	0.0	0.8	0.1	15.3	0.0	4.3	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.5	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	28.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	14.5	9.4	20.7	14.9	8.5	4.4	1.8	4.3	1.7	3.9	11.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	8.0	0.0	0.1	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	22.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	19.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.0	0.0	1.2	0.0	3.5	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0
AKAIN1	C18orf42	ENSG00000231824	"A-kinase anchor inhibitor 1"	P0CW23	18	5142911-5197503	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 10.2;brain: 22.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA049365	Uncertain					NA	NA				"Cluster 6: Brain - Smell perception"					"HPA049365: AB_2680729"					"unprognostic (4.86e-1)"						"unprognostic (1.49e-3)"				"unprognostic (7.05e-2)"			0.0	10.2	2.5	0.0	1.1	0.0	0.0	22.9	14.7	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.3	1.2	0.2	1.1	0.0	0.0	3.7	2.6	0.1	0.7	0.7	2.4	0.0	2.9	0.0	0.1	4.3	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.8	5.9	0.0	0.1	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	1.1	22.9	14.7	11.3	1.2	3.7	2.6	2.9	1.3	5.9	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASCL1	"ASH1, bHLHa46, HASH1"	ENSG00000139352	"Achaete-scute family bHLH transcription factor 1"	P50553	12	102957674-102960513	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.0;choroid plexus: 13.7;liver: 11.1;pituitary gland: 30.1"	"Group enriched"	"Detected in some"	5	"Astrocytes: 17.0;Enteroendocrine cells: 36.4;Oligodendrocyte precursor cells: 42.7"	"Group enriched"	"Detected in many"	6	"glioma: 21.4;lung cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"SCLC-21H: 53.7;SH-SY5Y: 29.0"	"Low region specificity"	"Detected in all"							"HPA029217, HPA076307"	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA029217: AB_10669595, HPA076307: "	"unprognostic (7.92e-2)"	"unprognostic (4.37e-3)"		"unprognostic (4.55e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.10e-6)"	"unprognostic (3.40e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.52e-2)"	0.0	1.1	18.7	0.0	18.3	0.0	0.0	18.9	23.0	0.5	13.7	0.1	0.0	0.2	0.0	0.0	0.8	0.0	0.0	18.2	16.8	0.0	11.1	0.5	0.5	20.1	18.1	0.4	0.2	0.0	30.1	0.0	18.5	0.3	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	1.2	0.1	18.7	5.5	0.1	0.0	0.0	0.0	0.3	19.4	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.7	29.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	18.3	18.9	23.0	18.2	16.8	20.1	18.1	18.5	19.9	18.7	19.4	0.1	0.0	0.0	17.0	0.3	0.0	0.3	0.0	0.0	4.3	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.9	0.0	36.4	0.0	1.7	0.0	0.0	0.2	4.6	0.1	0.0	0.0	0.0	1.8	0.1	5.0	4.1	0.0	6.1	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	2.4	0.0	42.7	0.3	0.2	0.0	0.4	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.5	0.2	0.1	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.4
ATCAY	BNIP-H	ENSG00000167654	"ATCAY kinesin light chain interacting caytaxin"	Q86WG3	19	3879864-3928082	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 46.6;pituitary gland: 25.6;retina: 17.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 128.5;Excitatory neurons: 67.0;Horizontal cells: 47.1;Inhibitory neurons: 82.2;Oligodendrocyte precursor cells: 94.0"	"Cancer enriched"	"Detected in some"	8	"glioma: 15.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 7.3;SCLC-21H: 13.2;SH-SY5Y: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017755	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"			"HPA017755: AB_2669655"	"unprognostic (7.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.83e-4)"	"unprognostic (7.22e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.67e-1)"	0.1	6.9	32.1	0.6	34.6	0.3	0.0	0.5	46.6	0.9	0.0	1.1	0.5	0.1	0.1	0.2	0.0	0.2	0.1	29.8	36.1	0.1	0.0	0.1	0.2	17.8	13.8	0.1	0.3	0.0	25.6	0.1	16.7	1.8	0.3	17.6	0.1	3.2	1.2	0.3	0.6	0.2	3.3	0.1	0.4	0.2	17.3	0.0	0.1	0.0	0.0	0.1	0.6	24.6	0.5	0.1	2.7	0.3	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.6	0.5	0.2	0.0	1.5	0.4	0.2	0.0	0.0	0.2	0.2	0.8	1.1	0.2	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.5	0.5	0.1	0.2	0.2	0.4	7.3	0.1	0.1	0.2	0.4	0.2	0.1	0.2	13.2	9.3	0.2	0.2	0.1	1.2	0.2	0.2	0.5	0.3	0.6	0.4	0.7	0.3	0.3	0.2	0.3	1.3	0.2	0.6	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.6	0.3	0.1	0.1	0.1	0.1	32.1	34.6	0.5	46.6	29.8	36.1	17.8	13.8	16.7	3.3	17.3	24.6	0.2	0.0	3.4	3.3	0.6	0.6	0.8	0.0	0.0	128.5	0.2	0.1	1.9	2.8	0.0	0.0	22.9	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.9	0.7	0.0	0.0	67.0	0.0	0.2	1.1	0.0	0.8	7.0	0.1	0.7	0.1	0.1	47.1	82.2	0.2	0.0	0.6	2.6	0.0	0.0	0.5	3.6	5.6	0.1	5.4	2.1	94.0	3.9	0.0	0.0	0.4	0.0	0.5	0.0	0.1	0.0	18.7	0.0	1.9	0.7	0.7	1.7	0.0	0.4	0.0	0.6	0.0	0.1	0.4
CABP7	MGC57793	ENSG00000100314	"Calcium binding protein 7"	Q86V35	22	29720003-29731833	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 38.2"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 28.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.3;ovarian cancer: 1.0;pancreatic cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 10.3;SCLC-21H: 9.7;SH-SY5Y: 3.1;U-2 OS: 3.1"	"Group enriched"	"Detected in all"	4	"cerebellum: 74.4;hippocampal formation: 204.8;midbrain: 60.3;pons and medulla: 110.0"	"Region enhanced"	"Detected in all"		"hippocampal formation: 51.0"	HPA016439	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA016439: AB_2669357"	"unprognostic (1.88e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.05e-3)"	"unprognostic (7.96e-2)"	"unprognostic (8.69e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.44e-7)"	"unprognostic (1.25e-4)"	"unprognostic (3.60e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.72e-3)"	0.1	5.6	3.1	0.0	3.0	0.2	0.1	19.8	35.0	0.1	0.6	0.8	0.4	0.1	0.0	0.1	0.1	0.0	0.2	38.2	4.2	0.2	0.3	0.1	0.1	27.7	14.8	0.1	3.1	0.0	0.4	0.0	30.0	0.4	0.0	1.0	0.2	0.0	0.1	0.2	1.5	0.0	22.2	0.4	0.3	0.6	3.9	0.0	0.3	0.0	0.0	0.1	0.1	16.5	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.5	10.3	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.0	0.0	9.7	3.1	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1	3.1	0.1	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.1	3.1	3.0	19.8	35.0	38.2	4.2	27.7	14.8	30.0	22.2	3.9	16.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	28.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.8	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	1.1	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	1.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.0
CALCA	"CALC1, CGRP, CGRP-alpha"	ENSG00000110680	"Calcitonin related polypeptide alpha"	"P01258, P06881"	11	14966668-14972351	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, Transporters"		Hormone	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 178.3;thyroid gland: 154.2"	"Cell type enriched"	"Detected in some"	64	"Ionocytes: 2368.1"	"Cancer enriched"	"Detected in many"	7	"lung cancer: 64.7"	"Region enhanced"	"Detected in many"		"pons: 34.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"pons and medulla: 57.9"					"HPA059886, HPA064453"	Enhanced	Supported			"Secreted to blood"	NA	NA	51500			"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA059886: , HPA064453: "			"unprognostic (1.97e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (5.99e-2)"		"unprognostic (2.42e-1)"	"unprognostic (1.17e-1)"		"unprognostic (6.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.02e-2)"	0.7	0.2	0.6	1.5	0.6	0.0	0.2	0.6	0.5	0.2	0.0	0.6	0.0	0.2	0.0	0.1	0.3	0.2	1.1	0.3	0.8	46.4	37.5	2.4	0.1	20.9	7.0	0.1	0.4	178.3	0.8	0.0	34.4	2.5	0.1	0.0	0.1	0.0	0.5	0.0	0.1	1.5	1.5	3.0	0.2	0.2	0.6	0.3	154.2	0.0	0.0	4.3	0.4	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.5	0.3	0.8	20.9	7.0	34.4	1.5	0.6	10.4	0.1	0.0	0.0	0.0	0.2	0.3	0.4	35.4	0.0	0.0	0.0	0.1	0.4	0.0	0.3	36.8	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.3	0.0	0.0	0.7	4.4	0.3	0.0	0.0	0.0	2368.1	0.0	4.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.2	0.0	0.0	0.4	5.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4
CALCB	"CALC2, CGRP-II, FLJ30166"	ENSG00000175868	"Calcitonin related polypeptide beta"	P10092	11	14904997-15082342	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Hormone	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 18.9;thyroid gland: 20.7"	"Group enriched"	"Detected in some"	4	"Melanocytes: 5.4;Spermatogonia: 5.1"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 1.2;endometrial cancer: 2.4;thyroid cancer: 0.9"	"Group enriched"	"Detected in many"	4	"hypothalamus: 6.8;medulla oblongata: 8.9;midbrain: 11.6;pons: 18.9;white matter: 4.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 5.8;Karpas-707: 10.4;SH-SY5Y: 3.5;U-266/70: 16.0"	"Region enriched"	"Detected in some"	7	"pons and medulla: 9.6"	"Group enriched"	"Detected in many"	5	"amygdala: 30.4;basal ganglia: 74.3;hypothalamus: 50.1;midbrain: 33.9;pons: 41.7"	HPA059886		Supported			"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA059886: "	"unprognostic (7.84e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.42e-5)"	"unprognostic (2.02e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.33e-1)"	0.3	0.0	0.1	0.3	0.2	0.0	0.2	0.5	0.6	0.2	0.1	1.4	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.3	6.8	1.0	0.8	0.1	0.1	8.9	11.6	0.1	1.5	0.3	2.2	0.1	18.9	0.1	0.2	0.1	0.3	0.0	0.8	0.1	0.4	0.1	2.3	0.1	0.1	0.3	1.0	0.0	20.7	0.1	0.1	0.0	0.1	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.2	5.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	1.9	0.0	0.4	0.1	0.0	10.4	0.0	0.0	0.0	0.6	2.9	0.1	0.1	0.4	0.0	0.2	0.0	0.0	1.1	3.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	16.0	0.6	0.4	2.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.6	0.3	6.8	8.9	11.6	18.9	2.3	1.0	4.7	0.0	0.0	0.0	0.3	0.2	1.3	0.1	0.0	0.0	0.0	0.6	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.4	0.2	0.9	0.5	0.2	0.5	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.3	0.0	0.0	5.4	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.9	5.1	0.0	0.0	0.1	1.2	0.0	0.0	0.1
CALY	"CALCYON, DRD1IP, NSG3"	ENSG00000130643	"Calcyon neuron specific vesicular protein"	Q9NYX4	10	133324072-133336935	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 236.9;pituitary gland: 167.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 155.7;Excitatory neurons: 72.6;Horizontal cells: 72.3;Inhibitory neurons: 128.5"	"Cancer enriched"	"Detected in some"	4	"pancreatic cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042283	Enhanced					NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 56: Bipolar cells - Visual perception"			"HPA042283: AB_10794417"	"unprognostic (1.43e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.41e-2)"	"unprognostic (7.32e-2)"	"unprognostic (9.81e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (1.23e-2)"	"unprognostic (4.19e-10)"	"unprognostic (8.04e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.63e-1)"	0.2	17.9	55.4	0.8	42.4	0.1	0.1	2.5	75.0	0.2	0.0	4.7	2.4	0.0	0.1	0.1	0.2	0.0	0.2	38.1	236.9	0.2	0.3	0.4	0.2	47.6	74.8	0.2	3.4	0.6	167.6	0.0	71.8	0.5	0.5	11.1	0.2	0.1	0.1	0.3	2.3	0.3	30.1	0.6	2.4	4.3	88.5	0.0	0.4	0.0	0.1	0.2	0.9	35.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.4	42.4	2.5	75.0	38.1	236.9	47.6	74.8	71.8	30.1	88.5	35.0	0.2	0.0	0.0	26.1	0.1	0.3	0.0	0.0	0.0	155.7	0.8	0.9	2.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	2.2	0.0	0.5	0.6	19.5	0.0	72.6	0.0	0.0	1.3	2.0	0.0	0.0	0.0	0.0	0.0	0.1	72.3	128.5	1.5	0.0	0.0	0.4	2.0	0.0	0.2	0.0	18.7	0.0	11.5	0.0	10.6	20.1	0.6	0.0	0.4	0.1	0.6	0.0	0.4	0.0	31.7	0.0	0.2	0.5	16.3	7.9	0.0	0.0	0.3	2.8	0.2	0.1	0.0
CASR	"FHH, GPRC2A, HHC, HHC1, NSHPT"	ENSG00000036828	"Calcium sensing receptor"	P41180	3	122183668-122291629	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"parathyroid gland: 654.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 25.6;Alveolar cells type 2: 20.2;Cholangiocytes: 27.1;Distal tubular cells: 13.7;Enteroendocrine cells: 11.5;Granulosa cells: 20.7;Respiratory ciliated cells: 15.3"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 5.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA039686, HPA050335"	Enhanced					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 40: Granulosa cells - Unknown function"			"HPA039686: AB_10673536, HPA050335: AB_2681092"		"unprognostic (1.97e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (8.55e-4)"	"unprognostic (1.58e-1)"	"unprognostic (7.32e-2)"		"unprognostic (7.67e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.91e-5)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.24e-2)"	0.1	0.1	1.5	0.1	1.0	0.8	0.0	1.7	1.6	0.0	0.3	0.1	0.8	0.0	0.1	0.0	0.1	4.2	0.0	1.0	0.6	22.4	0.2	0.0	0.2	0.6	1.1	0.5	9.6	654.4	0.2	0.0	0.8	0.1	0.2	1.5	0.1	0.0	0.1	0.2	0.5	0.0	0.2	0.1	2.8	0.2	1.7	0.1	0.7	0.0	0.2	0.3	0.0	1.7	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.8	0.3	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.5	1.0	1.7	1.6	1.0	0.6	0.6	1.1	0.8	0.2	1.7	1.7	0.0	25.6	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	27.1	5.6	3.7	0.0	0.0	0.0	0.0	13.7	4.3	0.5	0.0	0.0	0.5	11.5	0.0	0.3	0.2	0.0	1.6	0.0	0.0	1.3	20.7	0.0	0.1	0.1	0.0	0.1	0.6	0.0	1.0	0.0	1.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.4	0.0	0.0	0.0	0.2	15.3	1.0	0.0	0.0	1.5	0.0	0.5	0.0	0.0	0.0	0.9	0.8	0.0	0.0
CDK5R2	"NCK5AI, P39, p39nck5ai"	ENSG00000171450	"Cyclin dependent kinase 5 regulatory subunit 2"	Q13319	2	218959666-218962155	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 52.2;pituitary gland: 35.2;retina: 26.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 78.8;Cone photoreceptor cells: 20.9;Enteroendocrine cells: 22.8;Excitatory neurons: 17.7;Horizontal cells: 15.2;Rod photoreceptor cells: 50.9"	"Cancer enhanced"	"Detected in some"		"glioma: 3.9;pancreatic cancer: 2.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 18.4;SH-SY5Y: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (1.96e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.85e-5)"	"unprognostic (1.73e-6)"	"unprognostic (3.67e-2)"	"unprognostic (2.83e-4)"		"unprognostic (1.27e-3)"	"unprognostic (7.21e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.53e-3)"	"unprognostic (2.34e-10)"	"unprognostic (1.54e-1)"	"unprognostic (1.64e-4)"		"unprognostic (6.46e-2)"	0.0	3.9	17.0	0.3	21.5	0.0	0.0	0.0	52.2	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	20.2	17.4	0.0	0.0	0.0	0.0	7.1	3.6	0.0	1.0	0.0	35.2	0.0	10.7	0.0	0.1	26.3	0.0	0.0	0.0	0.0	0.4	0.1	1.4	0.0	0.9	0.8	15.6	0.0	0.0	0.0	0.0	0.0	0.1	20.0	0.4	0.4	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	2.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.3	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	18.4	13.3	0.7	0.0	0.1	0.4	0.0	0.0	0.0	0.2	1.3	0.0	0.3	0.0	0.0	0.0	0.6	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	21.5	0.0	52.2	20.2	17.4	7.1	3.6	10.7	1.4	15.6	20.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	78.8	0.0	0.0	0.5	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	22.8	0.0	17.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.2	11.9	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	8.1	0.0	2.0	2.6	0.2	1.2	0.0	0.0	0.1	0.1	0.0	0.0	50.9	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1
CEACAM5	"CD66e, CEA"	ENSG00000105388	"CEA cell adhesion molecule 5"	P06731	19	41708585-41730433	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell adhesion"		"Cancer-related genes, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 981.2"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 1389.2;Intestinal goblet cells: 395.0;Paneth cells: 777.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 1007.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 56.9"									"CAB000021, CAB000022, HPA011041, HPA019758"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		23000000		"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB000021: , CAB000022: AB_2335697, HPA011041: AB_1078481, HPA019758: AB_1846326"	"unprognostic (1.54e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.80e-1)"		"unprognostic (1.38e-2)"		"unprognostic (2.22e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.67e-9)"	"unprognostic (2.92e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.85e-1)"	3.2	0.1	0.0	185.6	0.0	0.2	4.0	0.3	0.1	38.5	0.2	981.2	22.7	1.3	0.2	232.0	0.8	0.8	0.1	0.1	0.0	0.9	0.2	30.2	0.1	0.1	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.5	942.7	0.0	29.2	3.3	0.1	3.5	61.4	28.7	0.0	0.1	163.2	0.3	0.1	0.2	1.0	0.0	36.9	10.4	71.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.1	0.0	0.0	13.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.3	56.9	1.1	0.2	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	32.1	4.1	0.0	2.7	0.0	1.0	12.3	0.0	0.0	0.1	0.0	0.4	0.0	34.8	0.0	0.0	0.0	0.0	1389.2	0.0	3.4	0.4	0.0	0.0	0.2	65.7	0.0	0.1	0.9	0.0	0.4	22.4	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.1	395.0	4.1	0.0	0.4	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	21.3	777.3	0.0	0.1	16.5	10.2	0.0	4.5	0.0	0.0	0.1	0.4	0.8	0.5	1.9	0.0	0.0	1.2	0.0	192.3	124.4
CELF3	"BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4"	ENSG00000159409	"CUGBP Elav-like family member 3"	Q5SZQ8	1	151700058-151716803	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 70.7;pituitary gland: 109.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 101.4;Cone photoreceptor cells: 39.6;Enteroendocrine cells: 52.8;Excitatory neurons: 21.1;Horizontal cells: 20.2;Inhibitory neurons: 20.4"	"Group enriched"	"Detected in many"	5	"glioma: 4.4;pancreatic cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 42.1;SH-SY5Y: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006292	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA006292: AB_10602250"	"unprognostic (2.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.82e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.05e-2)"	0.1	11.2	41.9	0.2	41.1	0.3	0.0	22.1	70.7	0.0	0.0	2.1	3.0	0.0	0.0	0.0	0.8	0.0	0.1	48.5	37.5	0.1	0.0	0.1	0.0	8.6	16.4	0.0	6.1	0.0	109.0	0.1	10.9	0.1	0.7	23.6	0.0	0.0	0.0	0.1	2.1	0.2	5.2	0.0	4.9	3.1	28.5	0.0	0.1	0.0	0.0	0.1	0.2	20.5	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	42.1	29.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.9	41.1	22.1	70.7	48.5	37.5	8.6	16.4	10.9	5.2	28.5	20.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	101.4	0.0	0.0	0.9	0.0	0.0	0.0	39.6	0.1	0.0	0.3	0.0	0.0	13.1	0.3	0.0	0.0	52.8	0.0	21.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.2	20.4	1.5	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	6.0	0.7	0.1	0.1	0.0	0.0	0.1	0.0	0.8	0.0	5.5	0.0	0.0	0.1	2.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1
CHGA		ENSG00000100604	"Chromogranin A"	P10645	14	92923150-92935285	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 6568.4"	"Cell type enriched"	"Detected in many"	7	"Enteroendocrine cells: 6553.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 114.8"	"Group enriched"	"Detected in many"	16	"cerebral cortex: 326.0;white matter: 124.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	151	"SCLC-21H: 489.5;SH-SY5Y: 1339.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000023, HPA017369, CAB040544, CAB055506, CAB058688"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA	295000000	100000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: AB_2665574, HPA017369: AB_1846698"	"prognostic favorable (7.85e-5)"	"unprognostic (4.89e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.81e-13)"	"unprognostic (1.07e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (3.99e-4)"	14.5	1248.5	8.6	9.4	11.4	0.2	0.3	0.0	326.0	8.3	0.0	92.0	242.7	0.4	0.3	1.0	1.1	0.2	0.2	4.4	1.7	1.0	0.4	1.6	0.1	14.4	0.0	0.2	102.5	6568.4	446.2	0.0	4.1	12.2	105.2	11.0	0.2	0.3	0.1	0.6	179.9	0.9	0.0	0.1	364.5	77.7	4.3	0.6	24.6	0.0	0.0	1.3	1.2	124.4	0.0	0.5	2.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.8	2.7	0.0	0.0	0.2	0.0	1.4	0.0	0.0	489.5	1339.4	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	4.2	0.3	0.4	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	11.4	0.0	326.0	4.4	1.7	14.4	0.0	4.1	0.0	4.3	124.4	0.1	0.0	0.0	11.1	1.0	0.9	0.4	0.0	0.0	17.3	0.2	0.3	2.9	0.0	0.0	0.0	29.2	0.3	0.0	9.8	0.0	0.1	1.3	6.0	2.3	0.8	6553.1	0.0	59.5	0.4	0.1	4.1	195.7	0.5	0.0	0.5	0.0	0.0	1.5	16.8	37.7	820.4	14.2	0.0	0.0	7.9	39.7	0.1	7.2	15.9	2.0	3.7	0.0	10.6	12.8	46.5	137.8	137.3	0.0	6.6	36.7	0.0	0.0	16.2	0.0	0.0	0.2	4.7	2.2	0.0	0.0	0.3	0.2	0.4	25.9	5.1
CHGB	"SCG1, SgI"	ENSG00000089199	"Chromogranin B"	P05060	20	5911510-5925353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"adrenal gland: 3466.0;pituitary gland: 1425.3"	"Cell type enriched"	"Detected in many"	5	"Enteroendocrine cells: 1036.1"	"Cancer enriched"	"Detected in many"	6	"pancreatic cancer: 154.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"SCLC-21H: 355.0;SH-SY5Y: 541.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008759, CAB009403, HPA012602"	Enhanced	Supported	Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		6500000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706"	"unprognostic (1.79e-3)"	"unprognostic (7.72e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (7.96e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (8.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.01e-2)"	27.5	3466.0	17.1	5.3	9.9	0.8	2.1	134.2	90.9	0.6	0.0	7.9	60.2	1.6	4.2	0.6	13.7	0.4	71.9	101.9	92.2	8.3	0.7	2.4	3.1	76.5	100.2	25.8	92.8	6.4	1425.3	0.7	188.4	5.3	14.2	56.9	6.1	3.8	11.0	1.7	31.6	0.9	12.8	0.3	133.3	14.9	19.3	4.0	9.7	0.8	1.4	0.4	2.3	14.2	0.0	7.9	0.9	0.0	0.2	0.2	0.4	0.2	0.0	0.1	0.0	1.9	0.0	0.0	4.3	0.0	4.9	0.1	0.0	0.1	0.1	0.6	0.1	2.6	0.0	1.6	0.1	4.2	0.2	1.5	0.0	0.0	2.1	0.1	0.1	0.2	0.4	0.1	1.0	0.0	0.1	0.9	19.7	1.3	0.0	0.1	0.0	0.4	0.5	0.2	355.0	541.8	0.0	0.5	0.4	2.1	0.3	0.4	0.3	0.1	6.4	0.4	3.3	0.0	0.7	2.7	0.5	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	17.1	9.9	134.2	90.9	101.9	92.2	76.5	100.2	188.4	12.8	19.3	14.2	0.0	3.2	2.4	7.5	0.3	4.2	9.9	0.8	0.0	93.3	0.1	0.3	114.4	0.0	0.7	69.9	20.9	0.1	0.0	1.6	1.9	0.5	7.1	0.2	0.7	3.0	1036.1	0.0	31.6	0.4	0.0	18.9	4.1	0.3	0.0	202.8	0.0	0.3	0.1	75.7	28.8	61.9	65.1	0.3	9.5	8.3	0.9	1.6	7.2	9.4	1.1	13.7	1.0	7.5	5.2	22.9	17.7	0.4	0.0	3.3	3.2	0.3	4.4	75.6	13.1	3.0	1.6	76.6	41.8	0.0	3.7	0.3	1.0	3.0	2.2	4.2
CPLX2	"CPX-2, DKFZp547D155"	ENSG00000145920	"Complexin 2"	Q6PUV4	5	175796310-175884021	"Predicted intracellular proteins"	"Differentiation, Exocytosis, Mast cell degranulation, Neurogenesis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 308.9;epididymis: 128.6;pituitary gland: 65.6"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 36.6;Excitatory neurons: 44.7;Horizontal cells: 95.9;Inhibitory neurons: 35.9;Late spermatids: 32.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"A549: 496.4;Hep G2: 323.4;SCLC-21H: 201.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071191, HPA074390"	Supported		Uncertain	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"HPA071191: , HPA074390: "	"unprognostic (1.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.49e-3)"		"unprognostic (6.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.90e-5)"	"unprognostic (6.88e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.87e-2)"	0.7	28.3	239.7	1.0	136.0	0.0	0.1	78.2	291.5	0.0	0.0	3.5	2.1	0.0	128.6	0.1	0.0	0.0	0.2	308.9	62.3	0.1	0.2	1.3	0.0	62.2	98.8	0.2	9.0	0.1	65.6	0.0	50.2	0.2	1.4	19.4	0.1	0.0	0.2	0.1	1.6	0.3	0.0	0.0	5.0	3.0	19.6	0.1	0.2	0.0	0.0	0.1	0.5	157.7	0.0	496.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	323.4	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.3	2.1	15.2	0.1	0.0	0.0	0.6	0.0	0.2	201.3	16.3	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	239.7	136.0	78.2	291.5	308.9	62.3	62.2	98.8	50.2	0.0	19.6	157.7	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.2	36.6	0.0	44.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.9	35.9	1.0	0.0	0.0	0.0	32.9	0.9	0.0	0.0	4.7	0.0	1.1	0.0	5.5	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDC	AADC	ENSG00000132437	"Dopa decarboxylase"	P20711	7	50458436-50565405	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 165.8;kidney: 314.9;retina: 175.6"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 410.3;Proximal enterocytes: 391.5;Proximal tubular cells: 429.5;Rod photoreceptor cells: 498.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.5;liver cancer: 13.4;pancreatic cancer: 6.4;renal cancer: 18.7;stomach cancer: 9.9"	"Group enriched"	"Detected in many"	9	"midbrain: 86.3;pons: 29.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 54.5;Hep G2: 49.3;OE19: 83.6;SCLC-21H: 130.9;SH-SY5Y: 135.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"midbrain: 74.5;pons: 29.4"	HPA017742	Enhanced		Approved	"Actin filaments"		NA	NA		120000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Actin filaments"		"HPA017742: AB_1847832"	"unprognostic (1.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.49e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.36e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.16e-1)"	0.5	48.9	0.1	2.3	0.7	0.0	1.0	0.0	0.6	0.0	0.2	36.5	154.8	0.0	9.1	0.1	0.0	0.1	0.0	0.2	2.2	314.9	54.6	2.0	0.1	6.1	86.3	0.8	15.8	0.0	0.0	0.0	29.4	0.6	37.5	175.6	0.0	0.0	0.0	0.1	165.8	1.7	0.0	0.1	18.1	1.5	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	54.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.3	0.0	0.0	11.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	83.6	0.0	0.0	0.0	0.7	1.3	0.0	130.9	135.9	0.0	4.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.2	2.2	6.1	86.3	29.4	0.0	1.9	0.2	0.0	0.0	12.2	0.0	2.5	0.0	0.0	0.0	0.0	89.3	0.1	0.1	0.4	2.8	0.6	3.7	41.7	0.0	0.0	34.4	25.4	0.1	6.6	0.1	0.0	1.8	410.3	0.0	0.3	0.9	0.1	0.1	0.0	0.4	0.0	0.0	1.1	67.2	0.1	3.3	0.4	67.8	0.0	1.3	0.0	5.4	0.0	2.5	0.0	0.0	0.0	45.1	0.0	0.0	0.1	0.2	31.8	0.0	0.0	0.3	391.5	429.5	0.0	498.9	0.0	0.0	0.0	4.0	0.4	0.0	0.0	0.1	1.3	0.1	88.7	0.2
DNER	"bet, UNQ26"	ENSG00000187957	"Delta/notch like EGF repeat containing"	Q8NFT8	2	229357629-229714555	"Cancer-related genes, Predicted membrane proteins"	"Notch signaling pathway"	"Activator, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 73.0;brain: 147.5;choroid plexus: 143.8"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 123.3;Inhibitory neurons: 333.0;Oligodendrocyte precursor cells: 435.8;Oligodendrocytes: 247.7"	"Cancer enriched"	"Detected in many"	32	"glioma: 73.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"GAMG: 368.0;hTERT-HME1: 149.7;hTERT-RPE1: 409.5;U-138 MG: 252.2;U-87 MG: 149.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017320	Enhanced					NA	NA		7900000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA017320: AB_1847808"	"unprognostic (4.39e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.73e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.23e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (3.42e-4)"	"unprognostic (2.59e-2)"	"unprognostic (7.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (5.13e-3)"	2.0	73.0	88.3	1.3	121.0	0.0	2.3	139.7	82.9	2.0	143.8	5.2	0.4	2.8	5.7	0.3	4.1	0.2	11.8	72.3	130.9	11.2	0.1	1.0	0.3	121.3	121.0	0.6	0.9	8.9	30.3	0.4	117.8	1.9	1.1	60.5	43.4	0.4	0.8	10.3	1.6	1.2	124.7	0.1	10.7	1.0	147.5	0.5	0.1	0.5	1.2	0.8	1.1	137.2	0.4	1.9	3.9	0.3	0.6	0.5	0.0	0.2	1.4	8.6	2.6	0.0	1.1	0.0	0.4	0.1	368.0	0.1	0.3	1.2	4.3	0.0	0.1	0.0	12.4	0.0	1.4	0.0	0.1	2.6	9.3	6.5	149.7	409.5	0.0	0.0	0.0	0.3	2.3	0.1	0.0	0.0	2.5	0.2	14.0	0.1	1.6	0.0	14.6	0.0	30.3	2.5	0.8	0.1	0.8	0.4	0.1	0.0	0.0	252.2	0.0	8.5	39.7	0.0	0.0	0.0	149.6	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	88.3	121.0	139.7	82.9	72.3	130.9	121.3	121.0	117.8	124.7	147.5	137.2	0.1	0.0	0.0	68.9	0.0	0.4	5.9	1.9	1.8	123.3	1.6	0.6	12.2	0.0	1.4	3.7	14.6	0.0	0.0	0.0	1.9	0.2	7.3	4.1	1.5	0.6	28.7	0.0	24.1	1.3	0.2	4.3	0.0	6.7	0.0	1.6	0.0	0.0	0.1	11.8	333.0	0.0	6.1	0.0	0.8	1.9	5.9	0.9	19.6	8.4	0.1	52.0	0.0	435.8	247.7	0.3	0.0	6.0	0.0	4.5	0.0	1.2	34.1	55.0	0.0	0.1	0.8	1.2	1.1	0.5	0.0	0.1	0.2	0.6	0.1	0.5
FOXA1	HNF3A	ENSG00000129514	"Forkhead box A1"	P55317	14	37589552-37596059	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 74.7;stomach 1: 28.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 113.8;Basal squamous epithelial cells: 76.8;Breast glandular cells: 87.9;Enteroendocrine cells: 84.6;Prostatic glandular cells: 89.8;Respiratory ciliated cells: 66.7;Urothelial cells: 154.5"	"Group enriched"	"Detected in many"	5	"breast cancer: 80.0;prostate cancer: 127.0"	"Region enriched"	"Detected in single"	5	"midbrain: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 48.9;MCF7: 105.3;PC-3: 69.5;RT4: 96.7;SK-BR-3: 97.0;T-47d: 135.9"	"Region enhanced"	"Detected in some"		"midbrain: 1.1"	"Region enriched"	"Detected in single"	6	"midbrain: 5.4"	"CAB011595, HPA050505"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB011595: AB_2104842, HPA050505: AB_2681148"	"unprognostic (1.61e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.67e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.00e-4)"	0.2	0.1	0.0	1.6	0.0	0.0	22.3	0.0	0.0	1.5	0.0	12.4	8.4	0.1	0.6	11.9	2.4	2.3	0.0	0.0	0.3	0.1	26.9	7.5	0.0	0.1	3.5	0.0	0.5	0.0	0.7	0.0	0.2	74.7	10.4	0.0	19.3	0.3	0.0	1.3	4.8	0.2	0.2	0.0	28.0	0.4	0.7	0.0	0.0	0.0	2.3	20.5	4.4	0.0	4.9	4.4	0.0	2.8	0.0	0.0	0.5	0.0	0.4	0.0	0.0	21.3	2.7	0.0	1.4	0.0	0.1	23.4	13.2	3.3	0.1	0.0	23.4	0.0	4.1	48.9	0.0	0.0	0.2	0.0	0.7	0.0	0.4	1.9	0.0	0.4	0.9	0.0	0.0	105.3	0.1	0.3	0.0	32.0	69.5	0.0	1.1	0.4	9.9	96.7	11.8	0.0	4.8	97.0	0.0	0.0	135.9	0.4	0.0	0.9	0.1	0.4	3.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	3.5	0.2	0.2	0.7	0.0	0.3	28.9	43.5	0.0	0.1	1.0	113.8	47.8	76.8	0.0	87.9	34.8	1.3	30.0	52.3	3.7	0.0	0.0	0.5	27.5	0.0	1.5	0.4	2.7	0.2	1.2	84.6	0.0	0.0	2.4	0.0	1.0	35.7	4.4	2.5	0.0	1.1	31.7	0.0	0.0	0.0	34.9	42.7	0.9	0.3	0.9	0.0	0.7	3.6	0.0	1.0	0.0	0.0	0.0	0.0	4.3	27.2	0.0	1.2	89.8	4.9	0.0	66.7	0.0	0.0	0.0	2.3	0.9	1.2	62.9	0.1	0.0	1.4	0.1	27.9	154.5
GDA		ENSG00000119125	"Guanine deaminase"	Q9Y2T3	9	72114595-72257193	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 79.7;intestine: 94.8;kidney: 42.9;liver: 60.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 112.3;Excitatory neurons: 109.3;Glandular and luminal cells: 171.1;Paneth cells: 83.7;Proximal enterocytes: 321.3;Proximal tubular cells: 98.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 34.4;EFO-21: 127.9;HeLa: 46.4;hTCEpi: 62.3;OE19: 157.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"amygdala: 36.5;basal ganglia: 30.1;cerebral cortex: 60.0;hippocampal formation: 70.7;olfactory bulb: 18.3"	"HPA019352, HPA024099, HPA030387"	Enhanced		Approved	Nucleoplasm		No	NA		1500000	"Cluster 11: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351"	"unprognostic (2.64e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.56e-2)"	"prognostic favorable (2.66e-5)"	"unprognostic (2.23e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.30e-4)"	0.3	2.7	57.0	1.2	66.9	0.4	0.2	19.8	79.7	1.6	23.2	10.4	94.3	3.7	0.4	0.4	8.5	15.9	0.1	62.3	52.3	42.9	60.3	0.2	0.4	19.9	26.1	0.2	2.7	8.5	2.8	2.9	25.8	0.1	9.9	0.1	0.0	6.7	1.6	2.2	94.8	0.4	20.5	0.1	3.4	1.2	60.5	0.6	0.1	0.4	4.7	4.0	0.2	42.3	34.4	4.5	0.1	0.1	0.0	0.0	0.8	0.3	24.9	0.0	0.0	3.2	19.3	0.0	127.9	0.0	0.2	2.9	0.2	0.0	0.0	0.4	0.1	0.0	46.4	0.2	0.0	0.1	0.1	0.2	62.3	0.0	0.6	0.1	0.0	0.0	9.6	0.1	0.0	0.2	0.2	0.3	0.2	157.0	0.0	0.0	0.1	1.1	1.1	7.9	0.2	0.6	2.5	0.1	0.1	0.2	0.1	0.2	0.6	0.2	0.4	0.2	0.1	0.3	0.2	0.3	0.1	0.3	0.1	0.8	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.2	0.4	0.3	0.1	0.1	0.1	0.0	57.0	66.9	19.8	79.7	62.3	52.3	19.9	26.1	25.8	20.5	60.5	42.3	0.0	0.0	0.5	3.9	1.9	0.0	0.7	19.0	0.0	0.0	0.0	0.0	0.8	14.3	24.7	0.0	0.0	0.2	0.0	65.5	3.9	11.7	1.2	112.3	7.4	0.4	4.8	0.0	109.3	10.7	1.9	0.3	12.2	171.1	0.0	0.0	1.1	56.9	0.2	0.0	22.8	22.1	2.0	1.9	0.4	0.6	0.3	1.2	0.0	5.6	0.6	0.0	0.0	5.0	3.8	6.7	83.7	0.0	0.1	0.8	321.3	98.2	58.6	0.0	0.0	0.8	3.0	1.4	4.7	0.0	0.1	1.9	1.2	0.2	16.1	2.2
GFRA4		ENSG00000125861	"GDNF family receptor alpha 4"	Q9GZZ7	20	3659248-3663399	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"thyroid gland: 1.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.6;Late spermatids: 3.2;Proximal tubular cells: 1.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA				"Cluster 43: Testis - Unknown function"		"Cluster 43: Cardiomyocytes - Nuclear processes"													"unprognostic (3.50e-2)"						"unprognostic (2.36e-1)"		0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.3	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRIA2	"GluA2, GLUR2, GLURB"	ENSG00000120251	"Glutamate ionotropic receptor AMPA type subunit 2"	P42262	4	157204182-157366075	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.4;retina: 29.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 335.0;Bipolar cells: 252.7;Excitatory neurons: 1090.5;Inhibitory neurons: 725.5;Oligodendrocyte precursor cells: 1106.8;Oligodendrocytes: 324.7"	"Group enriched"	"Detected in some"	10	"breast cancer: 2.7;endometrial cancer: 2.6;glioma: 6.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008441	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA008441: AB_1078983"	"unprognostic (1.36e-1)"	"unprognostic (9.60e-3)"		"unprognostic (4.15e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"		"unprognostic (8.70e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.40e-2)"	"unprognostic (2.91e-5)"	"unprognostic (2.42e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.55e-2)"	0.3	6.9	32.8	0.2	60.2	0.0	1.1	11.4	77.4	9.2	0.0	0.2	0.1	17.0	11.5	0.1	11.0	0.0	0.1	78.4	11.3	0.4	0.0	0.2	0.0	0.0	7.4	0.6	1.4	0.0	21.7	0.1	0.0	0.8	0.1	29.0	4.1	2.3	0.2	1.6	0.1	6.2	1.4	0.2	1.2	1.4	37.3	0.1	0.0	0.6	0.0	0.1	0.4	43.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	2.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	60.2	11.4	77.4	78.4	11.3	0.0	7.4	0.0	1.4	37.3	43.2	0.0	0.0	0.0	335.0	0.0	0.0	0.0	0.0	0.0	252.7	2.1	1.0	2.3	0.0	0.0	0.0	43.8	0.0	0.1	0.0	0.0	0.0	0.1	1.7	1.1	0.3	0.0	0.0	1090.5	0.0	0.0	0.2	0.0	2.7	0.0	0.1	0.0	0.0	0.1	138.0	725.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	58.1	0.0	4.2	0.0	1106.8	324.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.5	3.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1
GRP		ENSG00000134443	"Gastrin releasing peptide"	P07492	18	59220158-59230774	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1;stomach 1: 12.3"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 24.4;Early spermatids: 15.5;Ionocytes: 6.1;Late spermatids: 12.2;Sertoli cells: 6.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 7.6"	"Region enriched"	"Detected in all"	4	"midbrain: 26.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"BJ hTERT+: 5.1;fHDF/TERT166: 6.6"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 24.9"						"Secreted in other tissues"	NA	NA	340000			"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (3.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.30e-3)"	"unprognostic (3.21e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.01e-3)"		"unprognostic (1.14e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.86e-4)"	"unprognostic (2.65e-4)"	"unprognostic (9.94e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.16e-2)"	0.3	0.2	3.2	0.2	2.6	0.0	2.6	1.3	5.0	0.1	2.8	2.1	0.1	0.3	0.3	0.0	0.0	0.3	0.0	6.1	6.0	0.4	0.0	9.0	0.0	3.0	26.1	0.0	1.2	7.0	3.9	0.0	2.4	2.7	0.1	0.5	0.0	0.1	0.0	0.4	0.7	1.2	2.6	0.3	12.3	2.4	3.5	0.1	6.1	0.0	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.2	0.0	0.0	0.0	0.4	0.0	6.6	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.6	1.3	5.0	6.1	6.0	3.0	26.1	2.4	2.6	3.5	1.6	0.1	0.0	0.0	0.0	0.0	0.4	0.1	3.2	0.0	0.0	0.4	24.4	0.1	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	2.0	0.5	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.3	12.2	0.3	0.1	0.0	4.7	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.1	6.6	0.0	0.2	1.2	0.9	0.0	0.0	0.0	0.3	0.0	0.0	4.2
HOXB8	"HOX2, HOX2D"	ENSG00000120068	"Homeobox B8"	P17481	17	48611377-48615292	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 114.1;epididymis: 48.1;kidney: 37.6"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 88.3;Distal tubular cells: 72.4;Endometrial ciliated cells: 21.3;Enteroendocrine cells: 44.1;Glandular and luminal cells: 26.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 33.3"	"Region enhanced"	"Detected in many"		"spinal cord: 114.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 34.0;HDLM-2: 17.2;HEK 293: 36.9;LHCN-M2: 17.3;RPTEC TERT1: 35.3"	"Region enriched"	"Detected in single"	65	"pons and medulla: 6.5"	"Region enriched"	"Detected in all"	5	"spinal cord: 51.2"	HPA075905			Supported	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA075905: AB_2686767"	"unprognostic (4.44e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.07e-5)"	"unprognostic (6.63e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.00e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (1.30e-7)"	"unprognostic (1.77e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.88e-3)"	7.2	7.2	0.1	1.5	0.0	0.0	2.7	0.0	0.0	10.7	0.0	4.7	0.0	2.8	48.1	0.0	1.4	0.0	0.0	0.0	0.0	37.6	0.0	0.4	0.0	36.4	0.0	0.1	0.1	0.8	0.1	0.3	1.8	1.0	1.2	0.0	0.0	20.8	0.4	0.5	7.1	1.5	114.1	0.1	6.6	1.0	0.0	0.0	0.1	0.0	0.0	3.7	0.7	20.8	2.1	5.3	0.0	0.8	0.7	1.0	0.8	0.0	0.0	0.0	0.0	0.3	0.8	0.0	34.0	5.3	0.6	0.0	0.1	0.0	0.0	17.2	36.9	1.0	0.1	0.0	0.3	0.0	5.5	1.1	0.0	0.1	0.0	0.7	2.1	0.2	11.6	0.0	17.3	0.0	0.0	0.4	0.0	11.3	0.0	0.0	3.6	0.1	35.3	1.0	0.0	0.1	0.6	0.0	5.4	0.1	0.4	0.0	8.8	0.0	1.6	0.1	0.7	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	36.4	0.0	1.8	114.1	0.0	20.8	4.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.4	1.0	0.0	0.0	88.3	0.0	0.0	0.1	1.8	72.4	0.0	0.3	21.3	2.1	2.6	44.1	0.0	0.0	0.0	0.8	0.3	0.0	26.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	0.0	0.7	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.2	2.7	8.9	0.0	0.0	0.0	0.1	0.8	2.3	9.2	0.0	0.0	0.0	0.3	0.0	5.0	0.0
HTR5A	5-HT5A	ENSG00000157219	"5-hydroxytryptamine receptor 5A"	P47898	7	155070324-155087392	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 8.7;Excitatory neurons: 7.6;Inhibitory neurons: 10.0;Late spermatids: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							CAB017467	Approved					NA	NA				"Cluster 6: Brain - Smell perception"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB017467: AB_2122566"					"unprognostic (1.62e-2)"										"unprognostic (1.15e-1)"			0.0	0.0	1.7	0.0	1.6	0.0	0.0	3.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.6	0.0	0.0	0.0	0.0	0.6	2.7	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	3.6	2.8	1.3	1.6	0.6	2.7	1.8	0.2	1.2	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INA	"NEF5, NF-66"	ENSG00000148798	"Internexin neuronal intermediate filament protein alpha"	Q16352	10	103277138-103290346	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 160.7;pituitary gland: 41.4;retina: 97.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 62.4;Cone photoreceptor cells: 22.9;Early spermatids: 41.4;Excitatory neurons: 28.7;Horizontal cells: 45.4;Inhibitory neurons: 39.8;Late spermatids: 26.5;Rod photoreceptor cells: 48.2;Spermatocytes: 20.3"	"Group enriched"	"Detected in many"	4	"glioma: 4.7;testis cancer: 18.2;urothelial cancer: 14.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 53.0;SCLC-21H: 103.3;SH-SY5Y: 58.7;SiHa: 71.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002059, HPA007572, HPA008057"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Intermediate filaments"	Cytosol	"CAB002059: AB_442031, HPA007572: , HPA008057: AB_1851833"	"unprognostic (1.77e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-1)"	0.2	12.1	34.2	1.2	35.5	0.0	0.0	63.3	160.7	0.0	0.0	3.3	0.6	0.0	0.0	0.6	0.0	0.1	0.0	31.8	109.5	0.0	0.0	0.2	0.1	107.9	37.5	0.0	2.0	0.4	41.4	0.1	98.1	0.2	1.2	97.3	0.1	0.0	0.0	0.8	1.1	0.8	25.3	0.0	1.1	2.7	72.8	1.7	0.1	0.0	0.2	1.1	0.5	51.9	0.0	25.4	11.8	0.0	0.1	0.0	19.3	13.3	3.3	3.1	0.3	0.0	0.0	0.0	5.4	0.9	1.5	1.9	11.0	0.0	0.7	24.6	4.9	0.0	6.8	0.1	0.2	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	2.7	0.4	0.0	0.0	0.0	13.6	0.0	53.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	103.3	58.7	71.6	0.1	0.0	2.7	0.0	0.7	0.1	0.0	0.1	0.0	0.0	3.4	3.1	0.0	0.1	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.2	35.5	63.3	160.7	31.8	109.5	107.9	37.5	98.1	25.3	72.8	51.9	0.1	0.0	0.0	6.2	0.0	0.3	0.1	0.0	0.0	62.4	0.0	0.4	0.5	0.0	0.0	0.0	22.9	0.2	0.0	0.1	0.0	0.1	41.4	0.4	0.2	0.9	7.8	0.0	28.7	0.0	0.2	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.5	45.4	39.8	0.0	0.0	0.0	0.0	26.5	0.3	0.1	0.0	2.8	0.0	8.7	0.0	1.0	5.4	0.4	0.0	0.4	0.0	0.5	0.0	0.0	0.0	48.2	0.0	0.0	0.6	20.3	4.1	1.0	0.4	0.1	0.1	0.1	0.0	0.6
INSM1	"IA-1, IA1"	ENSG00000173404	"INSM transcriptional repressor 1"	Q01101	20	20368104-20370949	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.4;pituitary gland: 29.2"	"Cell type enriched"	"Detected in some"	42	"Enteroendocrine cells: 506.7"	"Cancer enhanced"	"Detected in many"		"glioma: 9.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"SCLC-21H: 370.4"	"Low region specificity"	"Detected in many"													NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"				"unprognostic (1.86e-2)"	"unprognostic (5.25e-4)"	"unprognostic (7.59e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-3)"		"unprognostic (4.34e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.23e-1)"	"unprognostic (1.22e-1)"	0.2	7.1	2.4	0.6	5.9	0.0	0.0	13.4	3.1	0.0	0.0	1.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	4.6	0.0	0.0	0.0	0.5	0.9	2.5	0.0	2.9	0.0	29.2	0.0	1.5	0.2	1.8	0.1	0.0	0.2	0.0	0.1	2.1	0.0	0.4	0.2	5.1	0.4	3.3	2.8	0.0	0.0	0.3	0.1	0.0	2.1	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.1	3.2	19.4	0.0	0.0	370.4	0.3	0.0	0.3	0.0	1.1	0.9	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	5.9	13.4	3.1	2.5	4.6	0.9	2.5	1.5	0.4	3.3	2.1	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.9	0.0	0.0	0.2	0.1	0.1	506.7	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	1.4	10.8	0.0	0.0	0.7	0.0	0.0	0.2	3.6	0.0	11.9	0.0	0.0	0.5	3.1	1.5	2.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	2.1	0.0
KIRREL2	"DKFZp564A1164, FILTRIN, MGC15718, NEPH3, NLG1"	ENSG00000126259	"Kirre like nephrin family adhesion molecule 2"	Q6UWL6	19	35855861-35867136	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"pancreas: 70.0"	"Cell type enriched"	"Detected in some"	9	"Bipolar cells: 58.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.5;HMC-1: 33.0;JURKAT: 19.5;U-937: 7.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA071587, HPA074326"	Enhanced		Supported	"Centriolar satellite"	"Intracellular and membrane"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Centriolar satellite"		"HPA071587: AB_2732182, HPA074326: AB_2732251"	"unprognostic (1.28e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-6)"	"unprognostic (1.72e-1)"	"unprognostic (4.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.62e-2)"	0.5	0.0	0.5	0.2	1.4	0.1	0.0	0.3	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	1.1	0.0	0.0	0.8	0.4	0.4	0.0	70.0	0.0	0.9	0.1	0.4	0.0	0.1	11.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.6	0.5	0.6	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.7	1.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	1.1	0.7	0.0	0.1	0.0	3.6	0.1	2.9	0.0	0.1	21.5	0.1	0.0	0.0	0.3	0.0	0.0	33.0	0.2	0.0	0.0	0.0	0.0	0.0	19.5	0.2	0.3	0.0	0.2	0.6	0.1	0.2	0.1	0.0	5.5	0.0	0.0	0.0	0.0	4.1	1.3	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.8	1.3	0.3	0.0	0.0	0.0	0.4	0.0	7.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.3	1.0	0.8	0.1	0.4	0.4	0.4	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	1.8	0.1	0.2	0.1	0.0	0.0	0.4	6.0	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.7	5.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.7	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0
KLK11	"PRSS20, TLSP"	ENSG00000167757	"Kallikrein related peptidase 11"	Q9UBX7	19	51022216-51028039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 324.2;skin 1: 239.8;vagina: 186.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 152.1;Club cells: 217.9;Late spermatids: 339.0;Prostatic glandular cells: 234.8;Squamous epithelial cells: 176.4;Suprabasal keratinocytes: 217.1;Urothelial cells: 186.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 53.3"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 13.0;HaCaT: 41.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB026340	Approved				"Secreted in other tissues"	NA	NA		1800000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB026340: "	"unprognostic (4.23e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.78e-4)"		"unprognostic (2.08e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (2.92e-2)"	"unprognostic (4.16e-6)"	"unprognostic (3.90e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.53e-1)"	28.4	0.2	0.0	0.4	0.0	0.0	17.1	0.9	0.1	109.8	44.5	1.9	0.7	7.2	2.6	324.2	34.2	59.3	2.0	1.7	0.0	0.3	0.8	18.9	0.0	0.2	0.1	1.6	89.1	0.0	8.8	0.0	0.3	64.9	0.6	0.7	169.5	4.2	1.9	239.8	1.4	0.3	0.0	0.1	113.3	14.4	0.6	2.5	0.4	0.3	27.2	1.4	186.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	6.4	0.1	13.0	0.0	0.0	41.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	1.7	0.0	0.2	0.1	0.3	0.0	0.6	0.0	0.2	86.6	10.4	0.0	0.4	106.9	152.1	131.6	13.1	0.2	33.4	35.3	0.8	88.6	217.9	0.0	0.0	0.0	0.0	0.1	0.0	9.2	111.6	4.7	1.1	3.8	20.3	0.0	0.0	130.2	0.0	9.1	91.3	15.6	1.3	0.0	0.0	0.0	0.3	0.0	0.0	10.7	118.0	0.0	11.4	339.0	2.8	1.8	8.8	0.0	0.1	0.1	0.0	0.0	0.0	79.4	0.0	0.4	0.5	234.8	0.1	0.0	26.9	1.3	0.0	0.2	7.9	2.1	2.5	176.4	217.1	0.0	1.7	0.0	0.4	186.1
KLK12	KLK-L5	ENSG00000186474	"Kallikrein related peptidase 12"	Q9UKR0	19	51029092-51035230	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"cervix: 108.5;esophagus: 208.6;salivary gland: 64.7;vagina: 99.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 30.7;Enteroendocrine cells: 40.3;Intestinal goblet cells: 24.9;Ionocytes: 14.2;Late spermatids: 34.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025473	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"CAB025473: "	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.15e-1)"		"unprognostic (5.80e-3)"		"unprognostic (4.99e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.56e-1)"		"prognostic favorable (8.01e-4)"	"unprognostic (8.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	108.5	2.2	2.1	4.0	0.0	0.0	208.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.1	0.5	0.8	0.0	64.7	0.0	0.0	0.6	5.8	0.1	0.0	0.0	0.4	0.5	0.0	0.1	0.1	0.0	8.9	0.0	99.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.5	0.5	0.2	0.0	2.3	0.0	0.0	0.0	0.1	0.9	0.0	0.0	30.7	0.0	0.0	0.0	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.9	14.2	0.0	0.0	34.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.4	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.2	8.4	0.0	0.0	0.0	0.0	1.3	1.7
NEURL1	"h-neu, neu-1, NEURL, RNF67"	ENSG00000107954	"Neuralized E3 ubiquitin protein ligase 1"	O76050	10	103493979-103592552	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Notch signaling pathway, Translation regulation, Ubl conjugation pathway"	Transferase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 146.9;tongue: 60.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 93.8;Early spermatids: 128.7;Intestinal goblet cells: 105.4;Late spermatids: 461.2;Paneth cells: 183.4;Syncytiotrophoblasts: 113.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"intermediate monocyte: 45.1;non-classical monocyte: 112.0"	"Lineage enriched"	"Detected in many"	19	"monocytes: 112.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 13.7;HeLa: 8.6;HMC-1: 6.9;JURKAT: 7.4;SCLC-21H: 17.1;SiHa: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044204	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA044204: AB_10959383"	"unprognostic (1.21e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.58e-4)"	"unprognostic (1.31e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.91e-4)"	"unprognostic (3.23e-1)"	0.5	4.6	25.5	3.8	29.6	2.2	0.4	20.8	37.4	14.1	0.0	15.2	10.9	25.8	15.1	4.3	2.6	1.9	0.5	32.2	7.2	2.4	1.2	0.9	0.8	1.7	4.1	1.9	18.8	8.3	15.9	4.6	1.3	1.4	10.3	39.5	2.9	1.3	146.9	1.8	17.2	5.2	0.0	1.9	5.2	13.0	5.0	1.1	0.5	60.5	0.5	18.7	2.6	17.2	0.9	0.2	1.3	0.0	0.2	0.1	13.7	0.5	0.9	0.2	0.1	0.3	0.2	0.4	0.7	0.1	0.9	0.6	0.4	0.2	0.1	0.4	0.8	0.2	8.6	0.3	0.0	0.3	6.9	0.2	0.5	0.1	0.7	0.2	0.0	7.4	2.3	0.5	0.2	1.2	1.4	0.9	0.0	0.5	4.2	0.2	0.7	1.5	0.0	0.5	17.1	5.9	8.8	0.0	0.4	2.5	0.7	1.7	0.0	0.1	0.9	0.3	0.2	1.0	0.2	0.3	0.5	0.0	0.4	0.8	2.8	0.5	0.7	45.1	1.1	1.1	1.0	1.1	5.8	0.7	1.2	0.8	2.3	0.6	112.0	4.7	0.4	4.1	25.5	29.6	20.8	37.4	32.2	7.2	1.7	4.1	1.3	0.0	5.0	17.2	0.3	0.0	0.6	1.3	1.5	0.5	1.5	0.2	0.0	53.2	2.0	2.7	1.6	0.0	0.2	0.0	93.8	4.6	3.1	7.9	0.0	12.0	128.7	0.0	0.8	2.2	78.3	4.6	47.9	0.7	12.9	2.2	13.3	0.1	0.0	1.2	0.0	0.2	4.5	3.3	32.9	105.4	32.6	4.6	2.4	461.2	5.6	4.8	0.0	0.0	5.5	9.0	2.1	1.0	4.2	0.5	183.4	5.3	0.6	1.3	7.2	0.0	0.2	88.0	6.6	2.4	1.0	56.6	33.6	0.0	1.8	113.4	1.7	8.4	9.4	0.7
NSG2	"CALY3, HMP19"	ENSG00000170091	"Neuronal vesicle trafficking associated 2"	Q9Y328	5	174045706-174243501	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 198.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	8	"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	59	"SCLC-21H: 39.5;SH-SY5Y: 64.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046531, HPA056191"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA046531: AB_2732528, HPA056191: AB_2683062"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.36e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.20e-2)"	"unprognostic (9.31e-4)"	"unprognostic (1.55e-1)"	0.5	33.3	115.8	2.6	198.5	0.0	0.1	43.8	152.8	0.0	1.7	6.9	2.3	0.0	0.4	0.1	0.0	0.3	1.0	125.2	171.9	0.7	0.4	0.3	0.0	54.5	82.1	0.1	0.9	0.0	7.0	0.0	101.1	0.2	3.9	39.2	0.1	0.1	0.3	0.1	3.8	1.8	52.4	0.2	3.0	14.7	100.3	0.0	0.6	0.0	0.0	0.1	1.2	47.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	64.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.8	198.5	43.8	152.8	125.2	171.9	54.5	82.1	101.1	52.4	100.3	47.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PCSK1N	"BigLEN, PEN, proSAAS, SAAS, SCG8, SgVIII"	ENSG00000102109	"Proprotein convertase subtilisin/kexin type 1 inhibitor"	Q9UHG2	X	48831096-48835610	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 642.6;pituitary gland: 1243.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 3045.7;Horizontal cells: 437.4;Paneth cells: 628.8;Proximal tubular cells: 1601.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 2.4;memory CD4 T-cell: 5.0;memory CD8 T-cell: 4.9;naive CD4 T-cell: 2.0;naive CD8 T-cell: 6.4;T-reg: 1.8"	"Lineage enriched"	"Detected in single"	64	"T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"HEK 293: 58.9;PC-3: 148.5;SCLC-21H: 58.2;SH-SY5Y: 53.8;SiHa: 52.1;U-266/84: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003925, HPA064734"	Enhanced	Supported	Approved	Vesicles	"Secreted to blood"	NA	NA		3300000	"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA003925: AB_1079582, HPA064734: AB_2685339"	"unprognostic (2.44e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (3.36e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.79e-3)"	"prognostic favorable (1.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	2.2	29.5	177.1	0.5	135.6	0.0	2.0	21.6	212.8	18.2	118.8	19.2	9.6	34.1	2.9	0.9	6.9	0.2	16.0	105.6	642.6	152.1	1.3	2.9	0.1	290.3	257.1	2.3	54.0	11.1	1243.7	0.2	193.0	14.4	0.5	2.5	6.7	0.8	0.8	8.8	13.7	0.6	95.5	1.1	21.9	19.7	264.9	0.0	3.3	0.0	0.0	1.2	6.5	51.8	0.1	5.4	0.2	14.9	0.6	0.0	0.4	0.0	0.0	0.0	0.0	5.3	0.1	0.0	10.4	0.0	4.2	0.8	0.0	1.1	0.0	0.0	58.9	0.0	0.0	9.3	0.0	0.0	3.7	0.0	0.8	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	7.6	0.0	0.5	7.9	0.0	148.5	0.0	0.0	0.4	1.4	0.2	58.2	53.8	52.1	0.2	4.9	0.7	0.2	0.1	0.1	0.1	22.7	0.2	5.0	13.3	73.6	0.3	0.4	0.0	1.5	0.0	0.0	0.0	0.8	0.0	2.4	0.0	5.0	4.9	0.0	0.0	2.0	6.4	0.0	0.0	0.0	0.0	1.8	0.7	177.1	135.6	21.6	212.8	105.6	642.6	290.3	257.1	193.0	95.5	264.9	51.8	0.8	0.0	0.0	29.0	12.5	15.8	1.3	4.3	0.6	139.6	11.4	14.9	1.4	2.8	4.3	389.9	52.1	1.0	1.0	18.2	277.8	8.6	12.8	44.3	8.7	3.6	3045.7	2.7	64.8	0.7	69.0	17.2	112.1	35.2	0.0	2.5	0.0	0.5	1.7	437.4	118.8	218.9	54.9	0.3	17.2	52.9	3.4	10.5	56.9	22.5	0.4	96.2	1.0	72.9	26.0	23.1	628.8	7.2	4.5	30.4	21.6	1601.1	24.8	148.2	0.0	0.3	12.6	32.5	82.2	0.2	11.5	1.9	20.1	0.2	15.6	3.7
PTPRN	"IA-2, ICA512"	ENSG00000054356	"Protein tyrosine phosphatase receptor type N"	Q16849	2	219289623-219309648	"Disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Receptor	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 234.3;pituitary gland: 182.3"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 59.0;Cone photoreceptor cells: 60.5;Enteroendocrine cells: 47.1;Excitatory neurons: 44.6;Horizontal cells: 97.6;Inhibitory neurons: 48.1;Rod photoreceptor cells: 38.4"	"Group enriched"	"Detected in some"	12	"glioma: 5.3;pancreatic cancer: 18.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"U-2 OS: 66.4;U-87 MG: 249.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007152, HPA007179"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA		38000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 62: Horizontal cells - Visual perception"	"Endoplasmic reticulum"		"HPA007152: AB_2667759, HPA007179: AB_1079714"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-4)"	"unprognostic (2.91e-3)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (1.45e-7)"	"unprognostic (3.64e-2)"	"unprognostic (1.24e-4)"	"unprognostic (1.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.20e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.28e-10)"	"unprognostic (1.43e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.61e-2)"	0.7	25.2	91.6	4.8	98.3	0.6	0.2	12.2	139.0	0.2	0.0	5.3	1.6	0.3	0.0	0.3	0.1	0.3	0.3	116.6	234.3	0.3	0.2	0.2	0.1	62.4	85.5	0.2	36.3	0.0	182.3	0.2	138.1	0.4	0.8	21.4	0.1	0.0	0.1	0.9	2.0	1.6	22.2	0.1	6.0	0.7	98.9	0.0	0.4	0.0	0.0	0.9	0.9	70.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	2.5	0.0	0.8	0.0	0.1	0.0	0.0	1.2	4.6	6.8	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.8	1.9	0.0	0.6	8.4	0.0	20.8	0.0	0.2	0.0	0.0	0.4	0.5	1.5	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	10.8	0.0	0.0	0.0	9.0	0.0	0.1	0.0	0.1	66.4	0.0	0.2	0.1	0.3	1.1	249.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	91.6	98.3	12.2	139.0	116.6	234.3	62.4	85.5	138.1	22.2	98.9	70.1	0.0	0.0	0.0	5.5	0.1	0.1	0.1	0.1	0.0	59.0	0.1	0.1	2.0	0.0	0.0	0.0	60.5	0.0	0.1	0.1	1.9	0.1	0.3	0.1	0.2	0.7	47.1	2.7	44.6	0.0	0.3	1.9	2.6	0.0	0.0	0.0	0.0	0.3	0.1	97.6	48.1	0.7	2.0	0.0	0.4	0.8	0.3	1.8	1.8	4.7	0.0	6.0	0.0	1.5	4.0	2.7	0.0	0.0	0.1	0.2	0.0	0.1	0.0	38.4	0.0	0.1	1.9	4.2	2.7	0.0	0.1	0.0	0.1	0.0	0.1	0.2
RALYL	HNRPCL3	ENSG00000184672	"RALY RNA binding protein like"	Q86SE5	8	84182787-84921844	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 19.8;brain: 68.1;kidney: 19.2"	"Cell type enriched"	"Detected in some"	5	"Excitatory neurons: 2828.9"	"Cancer enhanced"	"Detected in single"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055868, HPA059112"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA055868: AB_2682950, HPA059112: AB_2683908"				"unprognostic (1.13e-5)"	"unprognostic (1.62e-1)"		"unprognostic (7.48e-2)"		"unprognostic (1.36e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.82e-5)"	"unprognostic (2.74e-2)"	"unprognostic (2.52e-1)"			0.1	19.8	31.9	0.2	35.2	0.2	0.1	68.1	40.2	0.0	0.0	0.7	0.3	0.1	0.7	0.0	0.6	5.0	2.3	27.0	27.5	19.2	0.3	0.1	0.1	12.3	17.3	0.0	2.3	0.0	6.1	1.2	22.7	0.2	0.4	9.0	0.6	2.0	0.2	0.2	0.6	0.1	7.6	2.4	0.5	0.4	26.5	0.0	0.1	0.3	0.1	0.1	0.1	28.5	0.1	0.0	4.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	31.5	0.2	0.0	0.4	0.0	0.0	0.0	0.7	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.4	0.2	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.9	35.2	68.1	40.2	27.0	27.5	12.3	17.3	22.7	7.6	26.5	28.5	0.0	0.0	0.0	50.6	0.0	0.0	0.0	0.0	0.0	38.5	1.0	0.6	5.0	21.5	0.0	7.3	2.1	0.0	0.0	0.0	178.1	1.0	2.2	0.0	0.0	0.9	1.8	0.0	2828.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	33.7	531.4	0.6	0.0	0.0	0.0	1.5	0.3	0.0	0.0	68.4	0.0	32.8	0.0	495.6	36.3	0.1	0.0	0.0	0.0	0.0	11.7	19.4	0.0	5.2	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	4.0	0.1	0.1
SCG2	"CHGC, SgII, SN"	ENSG00000171951	"Secretogranin II"	P13521	2	223596940-223602361	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 360.1;brain: 426.2;pituitary gland: 269.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 212.4;Enteroendocrine cells: 283.4;Inhibitory neurons: 109.9;Ionocytes: 138.4"	"Group enriched"	"Detected in many"	8	"glioma: 70.0;pancreatic cancer: 52.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 53.3;HSkMC: 45.9;hTERT-RPE1: 46.5;SCLC-21H: 47.6;SH-SY5Y: 20.7;WM-115: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011893, HPA075062"	Enhanced	Supported	Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		330000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Golgi apparatus"	Vesicles	"HPA011893: AB_1856656, HPA075062: AB_2732277"	"unprognostic (2.93e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.82e-4)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (5.58e-4)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.01e-10)"	"unprognostic (2.47e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-3)"	9.2	360.1	49.2	30.2	78.4	0.4	0.5	17.1	54.7	1.5	2.2	10.6	47.7	3.5	0.4	0.6	0.2	4.0	1.7	21.7	426.2	0.6	0.2	3.3	0.4	118.3	195.4	6.1	28.3	0.5	269.0	1.1	250.9	3.5	13.0	40.6	0.3	1.2	0.3	1.0	21.3	12.8	77.4	0.2	17.9	0.2	130.7	0.1	6.4	0.8	0.1	0.8	1.3	30.3	0.0	3.1	10.3	8.5	2.3	53.3	0.2	0.5	2.0	4.0	10.1	0.4	1.0	0.0	0.9	0.7	6.2	0.2	0.2	0.0	5.0	0.1	0.5	0.0	0.6	0.0	0.5	0.7	4.6	45.9	0.2	5.8	2.0	46.5	0.0	0.0	0.2	0.4	5.1	0.3	0.0	0.2	7.3	0.1	0.2	0.0	0.3	0.3	0.9	0.1	47.6	20.7	0.0	0.5	2.5	1.6	0.0	0.1	0.1	5.4	2.2	0.2	3.6	0.1	0.0	0.3	1.6	0.1	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.2	78.4	17.1	54.7	21.7	426.2	118.3	195.4	250.9	77.4	130.7	30.3	0.0	6.4	0.0	12.7	0.0	0.0	0.4	2.8	0.0	212.4	0.0	0.0	0.1	0.0	1.3	0.0	2.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.2	6.7	283.4	0.0	27.7	0.2	0.0	2.3	0.0	0.1	0.0	0.0	0.7	0.0	0.1	8.4	109.9	14.7	138.4	0.3	0.3	0.0	0.6	0.0	1.8	3.7	0.0	11.6	0.0	34.2	8.2	14.8	6.2	0.4	0.0	2.1	0.1	0.1	0.7	14.6	0.0	1.8	1.7	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.5	0.8
SCG3	"FLJ90833, SgIII"	ENSG00000104112	"Secretogranin III"	Q8WXD2	15	51681492-51721026	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 133.5;choroid plexus: 40.1;pituitary gland: 39.4;retina: 56.8"	"Group enriched"	"Detected in many"	4	"Astrocytes: 79.3;Bipolar cells: 120.4;Cone photoreceptor cells: 102.2;Enteroendocrine cells: 148.4;Excitatory neurons: 46.2;Horizontal cells: 148.0;Inhibitory neurons: 64.0;Ionocytes: 38.7;Oligodendrocyte precursor cells: 63.3;Rod photoreceptor cells: 93.3"	"Group enriched"	"Detected in many"	7	"glioma: 41.0;pancreatic cancer: 15.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 50.5;SCLC-21H: 121.2;SH-SY5Y: 57.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006880, CAB033274, HPA053715"	Enhanced	Supported	Supported	Vesicles	"Secreted in brain"	NA	NA		3100000		"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: AB_2682239"	"unprognostic (1.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	0.5	16.7	71.0	1.1	87.0	0.6	0.5	85.8	133.5	0.1	40.1	1.8	2.3	0.2	0.3	0.3	0.3	0.2	0.2	88.2	112.7	0.2	0.2	0.6	0.4	68.7	75.8	0.1	15.6	0.2	39.4	0.1	68.9	0.3	2.0	56.8	0.2	0.0	0.1	0.6	2.0	0.5	71.9	0.2	9.9	2.6	79.8	0.5	1.0	0.0	0.2	0.2	0.2	71.6	0.2	0.1	4.8	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.2	0.3	0.5	0.0	0.6	0.4	0.1	0.0	0.1	0.1	0.5	0.1	0.3	0.1	0.0	0.3	3.0	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.2	0.8	0.0	0.3	0.1	0.1	50.5	0.1	0.2	0.3	0.1	0.4	0.0	0.5	121.2	57.5	0.2	0.4	0.2	15.5	0.1	3.8	0.1	0.3	0.7	0.2	0.2	0.4	0.2	0.4	0.7	0.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	71.0	87.0	85.8	133.5	88.2	112.7	68.7	75.8	68.9	71.9	79.8	71.6	0.2	0.0	0.0	79.3	0.0	0.3	0.0	0.3	0.0	120.4	0.0	0.1	0.2	0.0	0.1	0.0	102.2	0.0	0.0	0.2	1.9	0.4	20.0	0.0	0.0	4.3	148.4	0.0	46.2	1.0	0.1	4.1	0.0	0.0	0.0	0.0	1.8	0.0	0.4	148.0	64.0	3.4	38.7	0.0	0.3	11.3	0.0	0.1	1.8	7.5	6.7	19.2	0.0	63.3	8.9	5.3	0.0	0.4	0.0	0.4	0.1	0.0	0.8	93.3	0.0	0.4	0.2	13.8	5.8	0.0	0.0	0.0	0.0	0.2	0.3	0.3
SCG5	"7B2, SGNE1, SgV"	ENSG00000166922	"Secretogranin V"	P05408	15	32641676-32697098	"Predicted secreted proteins"	Transport	"Chaperone, Neuropeptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 133.0;pituitary gland: 402.7"	"Cell type enriched"	"Detected in many"	4	"Enteroendocrine cells: 470.8"	"Group enriched"	"Detected in many"	5	"glioma: 38.2;pancreatic cancer: 82.9;thyroid cancer: 22.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 26.9;HSkMC: 33.5;NTERA-2: 15.3;SCLC-21H: 31.5;SH-SY5Y: 36.4;U-87 MG: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013136, HPA074618"	Enhanced				"Secreted to blood"	NA	NA		100000	"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA013136: AB_1856657, HPA074618: AB_2732262"	"unprognostic (1.71e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-3)"	"prognostic unfavorable (9.64e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.62e-3)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (4.51e-9)"	"unprognostic (3.57e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (8.88e-2)"	1.7	61.1	54.0	3.3	62.0	0.3	3.7	52.2	100.4	1.0	77.3	7.9	17.9	5.3	42.5	0.5	3.4	5.5	1.3	58.9	75.1	0.9	3.6	3.8	1.3	56.5	48.3	3.2	133.0	73.7	402.7	0.3	58.7	5.0	9.8	26.7	0.2	0.9	0.2	1.3	5.6	6.7	57.7	0.5	37.8	5.3	56.3	0.3	5.8	0.1	0.3	2.6	2.7	58.9	0.5	0.2	0.1	0.2	0.6	4.5	0.1	4.2	0.4	0.4	0.4	0.1	0.0	0.5	1.9	0.4	1.7	1.2	0.5	0.2	1.2	0.7	0.3	0.6	0.0	0.1	26.9	0.2	0.7	33.5	0.1	0.8	0.4	0.9	0.7	1.0	0.3	0.6	0.8	0.0	0.3	0.3	15.3	0.1	0.8	0.1	0.4	0.6	0.4	0.0	31.5	36.4	0.2	0.0	0.2	0.4	0.1	0.4	0.0	5.2	3.8	0.3	0.5	0.6	2.3	0.4	47.2	1.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.0	62.0	52.2	100.4	58.9	75.1	56.5	48.3	58.7	57.7	56.3	58.9	0.2	0.0	0.5	20.2	0.3	0.6	0.2	6.2	0.0	51.0	0.5	16.5	0.4	0.0	3.9	0.0	2.1	0.2	0.1	1.1	0.0	0.6	52.1	3.7	19.3	1.1	470.8	0.0	82.8	78.3	0.3	17.9	23.0	0.6	2.5	51.4	0.4	11.9	6.0	50.5	97.8	14.5	97.6	0.6	0.8	80.0	2.1	1.6	3.6	20.6	0.6	15.6	0.0	52.3	79.7	22.9	1.1	7.9	0.3	1.4	0.5	0.0	0.5	32.6	0.0	0.3	34.2	39.2	2.9	0.1	0.3	0.3	0.3	51.8	2.4	1.0
SLC7A14	"KIAA1613, PPP1R142"	ENSG00000013293	"Solute carrier family 7 member 14"	Q8TBB6	3	170459548-170586075	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 15.9;pituitary gland: 7.3;retina: 6.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 28.4;Excitatory neurons: 61.9;Horizontal cells: 28.6;Inhibitory neurons: 90.2;Oligodendrocytes: 67.4"	"Group enriched"	"Detected in some"	11	"glioma: 0.8;pancreatic cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 3.2;SCLC-21H: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045929	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA045929: AB_2679501"	"unprognostic (1.00e-1)"		"unprognostic (9.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.68e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.03e-6)"	"unprognostic (1.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.24e-3)"	0.0	2.3	8.9	0.4	8.1	0.1	0.0	5.5	8.8	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	7.9	15.9	0.1	0.0	0.0	0.0	15.6	6.4	0.1	0.7	0.0	7.3	0.0	14.9	0.1	0.4	6.1	0.0	0.0	0.1	0.1	0.3	0.1	4.0	0.0	0.2	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.1	0.0	0.5	0.9	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.9	8.1	5.5	8.8	7.9	15.9	15.6	6.4	14.9	4.0	8.9	7.7	0.8	3.2	2.2	4.6	0.1	0.4	0.3	0.1	0.0	28.4	0.1	0.0	1.0	0.0	2.5	0.0	2.1	0.1	0.1	0.0	0.0	0.0	0.6	0.2	0.2	0.5	1.8	0.0	61.9	0.0	0.1	0.4	0.0	0.1	2.5	0.1	0.4	0.9	0.0	28.6	90.2	0.1	0.0	0.0	1.2	0.6	2.1	0.4	3.6	6.5	0.0	1.8	0.0	9.5	67.4	0.1	1.2	2.6	0.1	0.3	0.1	0.2	3.0	4.3	0.0	0.7	0.5	0.0	0.2	0.0	0.6	0.0	0.4	0.1	0.0	0.2
SST	SMST	ENSG00000157005	Somatostatin	P61278	3	187668912-187670394	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 449.5;intestine: 386.6;pancreas: 479.4;stomach 1: 418.0"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 1404.1;Intestinal goblet cells: 460.2"	"Cancer enriched"	"Detected in many"	4	"pancreatic cancer: 1039.3"	"Region enhanced"	"Detected in all"		"hypothalamus: 449.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 22.4;U-2 OS: 44.7;U-251 MG: 7.6;U-698: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000075, HPA019472, CAB034105"	Enhanced	Supported			"Secreted to blood"	NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"CAB000075: AB_2688022, CAB034105: AB_2271061, HPA019472: AB_1857360"		"unprognostic (2.44e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (5.12e-3)"	"unprognostic (1.54e-2)"			"unprognostic (4.69e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.45e-1)"	5.5	43.0	59.9	4.6	52.1	4.2	0.5	1.3	67.8	0.6	2.5	31.8	386.6	0.7	0.1	1.6	0.4	1.1	1.3	30.6	449.5	6.2	0.3	0.3	1.5	96.9	48.1	2.4	479.4	0.0	9.3	0.1	50.3	1.3	23.8	6.3	0.1	21.6	0.1	8.9	133.3	2.8	137.8	0.2	418.0	0.2	117.2	1.1	1.0	0.0	0.0	7.3	1.8	18.7	0.0	0.0	0.8	0.1	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.3	0.5	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	44.7	0.4	7.6	0.0	2.9	11.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.9	52.1	1.3	67.8	30.6	449.5	96.9	48.1	50.3	137.8	117.2	18.7	0.0	0.0	0.0	9.1	0.5	0.0	0.0	3.3	0.0	0.0	0.2	0.1	0.0	0.0	0.1	5.5	0.0	0.1	0.0	4.3	0.0	0.0	0.3	0.3	0.5	0.1	1404.1	0.0	1.7	0.0	0.2	0.7	0.0	4.2	0.0	0.0	0.0	0.0	0.3	0.0	146.2	460.2	215.7	0.0	0.0	0.1	0.0	0.0	0.0	9.4	3.6	0.0	0.0	3.0	9.1	0.0	0.6	0.0	0.0	0.0	11.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.9	13.8	0.2
ST18	"KIAA0535, NZF-3, NZF3, ZC2H2C3, ZC2HC10, ZNF387"	ENSG00000147488	"ST18 C2H2C-type zinc finger transcription factor"	O60284	8	52110839-52460959	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 82.1"	"Cell type enriched"	"Detected in some"	39	"Oligodendrocytes: 4055.3"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.7;SCLC-21H: 9.6;U-87 MG: 1.5"	"Region enhanced"	"Detected in all"		"cerebellum: 40.2"	"Low region specificity"	"Detected in all"			HPA044919	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA044919: AB_10959756"	"unprognostic (3.66e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.53e-5)"	"unprognostic (3.29e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.84e-3)"	0.0	0.9	18.4	0.1	48.6	0.0	0.0	44.1	24.1	0.0	1.7	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	18.0	29.0	0.3	0.1	0.1	0.0	47.8	37.4	0.0	1.9	0.0	4.4	0.1	43.5	0.1	0.3	8.5	0.0	0.0	0.0	0.0	0.5	0.0	22.3	0.0	1.5	0.3	35.7	0.1	0.0	0.0	0.1	0.0	0.0	82.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	48.6	44.1	24.1	18.0	29.0	47.8	37.4	43.5	22.3	35.7	82.1	0.0	0.0	0.0	4.9	0.6	0.1	0.1	0.0	0.0	101.5	0.0	0.0	1.1	4.3	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	7.4	0.0	0.0	0.2	49.6	1.3	3.4	0.0	0.4	0.2	5.1	0.0	0.0	0.0	0.0	0.2	1.3	1.7	8.5	0.8	10.2	1.6	11.0	1.7	0.0	3.4	0.0	0.0	0.7	2.4	0.0	13.0	4055.3	0.3	0.0	0.0	0.1	0.3	0.1	0.8	0.0	4.5	0.0	0.0	0.1	0.3	0.3	0.0	0.3	0.1	0.1	0.0	0.3	0.0
ST8SIA3	SIAT8C	ENSG00000177511	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3"	O43173	18	57352557-57371731	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 21.7;pituitary gland: 8.1;retina: 7.5"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 29.9;Excitatory neurons: 74.9;Horizontal cells: 63.9;Inhibitory neurons: 56.7;Oligodendrocyte precursor cells: 22.1"	"Group enriched"	"Detected in some"	11	"glioma: 0.9;pancreatic cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	26	"NTERA-2: 4.4;SCLC-21H: 8.6;SH-SY5Y: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063398, HPA066783"	Enhanced		Supported	"Golgi apparatus"		No	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA063398: AB_2685004, HPA066783: AB_2685721"					"unprognostic (1.75e-1)"		"unprognostic (7.85e-2)"			"unprognostic (1.41e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.11e-1)"		"unprognostic (5.49e-2)"	"unprognostic (1.82e-1)"			0.0	4.3	8.0	0.0	21.7	0.0	0.0	6.7	15.6	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.9	0.0	12.5	14.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	8.1	0.0	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	9.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	21.7	6.7	15.6	12.5	14.5	0.0	0.0	0.0	0.0	2.1	4.9	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	1.6	5.7	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.4	2.3	0.0	0.0	0.1	0.0	0.0	74.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	63.9	56.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	4.7	0.0	1.2	0.0	22.1	3.8	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	2.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SYT4	"HsT1192, KIAA1342"	ENSG00000132872	"Synaptotagmin 4"	Q9H2B2	18	43267892-43277535	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.7;pituitary gland: 30.7;retina: 25.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 66.8;Cone photoreceptor cells: 22.9;Enteroendocrine cells: 28.7;Excitatory neurons: 50.9;Fibroblasts: 23.0;Inhibitory neurons: 34.1"	"Group enriched"	"Detected in some"	5	"glioma: 2.0;pancreatic cancer: 4.1;prostate cancer: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 245.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010574	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Plasma membrane"		"HPA010574: AB_2668309"			"unprognostic (2.91e-3)"		"unprognostic (2.03e-1)"			"unprognostic (2.37e-2)"		"unprognostic (2.87e-1)"	"unprognostic (7.67e-3)"	"unprognostic (5.30e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.80e-2)"		3.7	15.9	21.5	1.4	18.6	0.1	0.0	74.7	42.6	0.0	0.0	1.2	0.8	0.0	0.0	0.1	0.0	0.0	1.3	18.6	50.4	0.1	0.0	0.9	0.0	10.5	15.3	0.5	3.7	0.0	30.7	0.1	39.3	0.6	0.8	25.2	0.1	8.3	0.0	0.0	0.7	0.6	13.5	0.0	3.2	1.6	18.3	0.4	0.3	0.0	0.0	0.0	0.5	10.9	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.4	245.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	18.6	74.7	42.6	18.6	50.4	10.5	15.3	39.3	13.5	18.3	10.9	0.0	0.0	1.1	8.8	0.0	0.1	0.0	0.0	0.0	66.8	0.0	0.0	3.6	0.0	2.5	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	28.7	0.0	50.9	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.4	0.0	2.5	0.0	7.5	7.6	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.7	10.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	0.1
SYT5		ENSG00000129990	"Synaptotagmin 5"	O00445	19	55171196-55180289	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 72.6;pituitary gland: 59.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Enteroendocrine cells: 57.6;Excitatory neurons: 20.3;Late spermatids: 41.4"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 3.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"EFO-21: 27.1;HMC-1: 60.2;K-562: 22.7;OE19: 95.7;SCLC-21H: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078390	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA078390: AB_2732382"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.76e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (9.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.82e-1)"	"prognostic favorable (5.54e-4)"	"unprognostic (1.15e-3)"	"unprognostic (3.71e-7)"	"unprognostic (7.09e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.55e-1)"	0.2	9.7	40.1	1.9	46.0	0.5	0.1	0.0	72.6	0.8	0.0	2.0	1.3	0.1	0.0	0.2	0.2	0.2	0.2	53.4	58.5	0.1	0.1	0.2	0.2	12.2	20.3	0.0	2.5	0.7	59.3	0.0	22.1	0.1	0.7	4.4	0.0	0.0	0.1	0.8	1.1	0.5	13.3	0.1	1.9	5.4	32.4	0.2	0.1	0.0	0.3	0.1	0.3	39.9	0.2	0.2	0.4	0.4	0.9	0.0	0.3	0.6	0.0	0.0	0.9	0.0	1.1	1.7	27.1	0.0	0.8	0.7	0.0	0.0	0.0	0.3	0.1	0.3	0.2	0.1	1.1	0.1	60.2	0.7	0.2	0.0	0.1	0.0	0.5	0.5	22.7	3.8	0.0	0.6	0.5	0.0	0.1	95.7	3.8	0.1	0.4	0.3	0.0	0.1	15.9	7.1	0.0	1.1	0.9	0.0	0.5	0.1	0.1	1.4	1.3	1.7	0.1	0.2	1.4	0.9	0.5	0.1	0.3	1.4	0.2	0.3	0.1	0.1	0.1	0.2	0.0	0.1	0.5	0.2	0.1	0.1	0.9	0.3	0.1	0.2	0.1	0.1	40.1	46.0	0.0	72.6	53.4	58.5	12.2	20.3	22.1	13.3	32.4	39.9	0.2	0.0	0.0	3.3	1.0	0.6	0.1	1.4	0.0	2.8	0.1	0.6	1.1	0.0	0.4	0.0	4.2	0.0	1.0	0.8	0.0	0.3	15.4	9.1	0.3	0.1	57.6	2.7	20.3	0.4	0.1	0.3	5.6	0.2	0.0	0.7	0.4	0.0	0.2	6.7	11.9	0.8	4.1	0.6	0.0	41.4	0.3	0.1	0.0	3.7	0.1	0.4	0.0	1.5	2.5	0.9	0.1	0.4	0.1	0.1	2.1	0.0	4.0	0.4	0.0	0.0	0.7	8.2	7.6	0.0	0.1	0.0	1.0	0.2	0.6	0.4
TMEM179	"C14orf90, FLJ42486, TMEM179A"	ENSG00000258986	"Transmembrane protein 179"	Q6ZVK1	14	104474678-104605647	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 31.5;pituitary gland: 88.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 58.1;Horizontal cells: 65.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.7;pancreatic cancer: 3.1;testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 8.8;SCLC-21H: 37.3;SH-SY5Y: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002942			Uncertain	Mitochondria		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	Mitochondria		"HPA002942: AB_1078113"	"unprognostic (8.65e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-4)"	"unprognostic (8.68e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.71e-6)"	"unprognostic (1.70e-2)"	0.2	11.4	18.9	0.3	19.3	0.0	0.1	12.0	29.7	0.1	4.6	3.8	0.2	0.1	0.4	0.1	0.3	0.1	1.0	17.8	24.6	0.5	0.5	0.1	0.0	25.9	24.9	0.1	4.0	0.1	88.1	0.8	31.5	0.8	0.2	6.2	0.1	0.1	0.1	0.0	1.4	0.3	12.5	0.0	1.3	5.2	18.8	0.0	0.1	0.0	0.0	0.1	0.7	20.5	0.0	0.5	0.3	0.8	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	37.3	11.6	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	19.3	12.0	29.7	17.8	24.6	25.9	24.9	31.5	12.5	18.8	20.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	1.2	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	65.6	12.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	1.5	0.0	7.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.7	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0
TNR		ENSG00000116147	"Tenascin R"	Q92752	1	175315194-175743616	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 31.3;retina: 16.2"	"Group enriched"	"Detected in some"	6	"Horizontal cells: 580.5;Oligodendrocyte precursor cells: 2288.6"	"Cancer enriched"	"Detected in single"	46	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 1.9;U-937: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022343, HPA027134, HPA027150, HPA029859"	Enhanced				"Secreted in brain"	NA	NA		58000		"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB022343: , HPA027134: AB_1851983, HPA027150: AB_1851985, HPA029859: AB_10600916"	"unprognostic (1.04e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.79e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.03e-3)"	"unprognostic (7.26e-4)"	"unprognostic (4.48e-4)"	"unprognostic (3.26e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	0.0	1.4	30.7	0.2	24.3	0.1	0.0	15.2	26.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	31.3	27.7	0.0	0.4	0.5	0.2	23.3	16.4	0.0	0.4	0.0	2.7	0.0	20.3	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.4	0.0	20.8	0.2	0.3	0.4	18.2	0.1	0.1	0.0	0.3	0.0	0.0	30.5	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	30.7	24.3	15.2	26.3	31.3	27.7	23.3	16.4	20.3	20.8	18.2	30.5	0.0	0.0	0.0	20.2	2.4	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	226.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	580.5	179.6	0.0	0.0	0.0	0.3	1.6	0.0	0.1	0.0	3.7	0.0	1.8	0.0	2288.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	3.8	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0
TUNAR	"HI-LNC78, LINC00617, TUNA"	ENSG00000250366	"TCL1 upstream neural differentiation-associated RNA"		14	95876392-95925663	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	5	"brain: 42.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.1;Endometrial ciliated cells: 11.5;Endometrial stromal cells: 8.9;Excitatory neurons: 4.6;Glandular and luminal cells: 16.8;Spermatogonia: 3.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 16.3;HAP1: 7.0;NTERA-2: 11.8;SCLC-21H: 16.1;SuSa: 4.6"															NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"				"unprognostic (1.28e-3)"			"unprognostic (3.94e-1)"	"unprognostic (4.10e-2)"					"unprognostic (1.69e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (5.33e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.18e-1)"		0.0	0.1	6.3	0.1	42.5	0.3	0.4	5.6	10.8	0.3	0.0	0.0	0.1	6.5	0.1	0.0	8.5	0.1	0.0	9.5	9.6	0.2	0.0	0.0	0.3	30.8	12.0	0.1	2.7	0.0	1.2	0.0	30.5	0.0	0.0	8.5	0.0	3.5	0.0	0.1	0.0	0.0	11.6	0.1	0.5	1.3	23.0	0.1	1.1	0.0	0.2	0.0	0.0	3.9	0.0	0.1	16.3	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	7.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	11.8	0.0	0.1	0.7	0.0	0.0	0.4	0.1	16.1	1.3	0.0	0.1	0.0	4.6	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	42.5	5.6	10.8	9.5	9.6	30.8	12.0	30.5	11.6	23.0	3.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	1.3	0.0	0.0	0.0	2.8	11.5	8.9	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.1	3.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0
VGF	"SCG7, SgVII"	ENSG00000128564	"VGF nerve growth factor inducible"	O15240	7	101162509-101165569	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 1407.4"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 128.3;Horizontal cells: 225.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 236.3"	"Region enriched"	"Detected in all"	6	"hypothalamus: 1407.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 172.0;SK-MEL-30: 511.5;U-2 OS: 85.9;WM-115: 141.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055177, HPA072505"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1270000	3100000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus, Vesicles"		"HPA055177: AB_2682728, HPA072505: AB_2686528"	"unprognostic (3.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.19e-3)"	"prognostic unfavorable (4.25e-4)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.25e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.70e-3)"	"unprognostic (9.82e-3)"	"unprognostic (3.79e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.21e-1)"	2.1	3.1	23.7	0.8	24.8	0.1	0.1	5.5	174.6	0.0	0.0	0.5	0.1	0.7	0.0	0.0	0.0	0.0	0.1	22.7	1407.4	3.6	0.0	0.1	0.0	235.4	69.9	0.1	16.1	0.0	117.0	0.0	158.8	0.1	0.0	2.2	0.0	0.0	0.0	0.8	0.3	0.2	16.6	0.1	1.9	0.9	48.7	0.0	0.6	0.0	0.0	0.0	0.1	27.3	2.2	1.1	1.1	9.5	0.0	0.0	10.3	0.9	0.0	0.0	0.0	2.4	0.9	0.1	3.1	0.0	1.4	1.4	0.5	0.1	0.0	1.0	0.7	0.3	0.0	0.9	0.1	0.6	4.4	0.1	0.2	0.2	0.7	0.0	0.0	0.1	3.7	2.3	0.0	23.4	0.1	2.4	17.6	1.0	2.3	0.8	0.0	0.1	0.3	0.1	14.1	172.0	0.3	0.9	511.5	1.1	0.4	0.3	0.0	0.4	85.9	0.0	2.0	0.1	0.8	4.7	13.5	0.4	141.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	24.8	5.5	174.6	22.7	1407.4	235.4	69.9	158.8	16.6	48.7	27.3	1.7	0.0	0.0	3.6	0.9	1.5	1.0	0.0	1.2	22.0	0.9	0.6	2.9	0.0	0.0	0.0	0.0	1.5	1.0	1.3	29.4	0.3	0.1	0.4	0.4	0.9	128.3	0.0	22.7	0.0	8.4	0.3	3.1	0.5	0.0	1.4	0.0	0.0	0.6	225.4	37.7	4.5	0.0	0.0	0.4	0.6	0.6	0.7	0.0	11.2	0.0	2.1	0.0	4.0	4.8	5.9	2.8	0.0	0.9	4.3	2.7	1.2	0.0	5.0	0.0	0.1	0.8	0.2	4.3	0.6	2.3	1.4	0.5	5.4	2.3	0.6